Recombinant CD22 (Pinatuzumab Biosimilar) antibody
The Humanized Chimeric anti-CD22 (Pinatuzumab Biosimilar) antibody has been validated for not_set. It is suitable to detect CD22 (Pinatuzumab Biosimilar) in samples from Human.
Catalog No. ABIN7597912
$401.14
Plus shipping costs $50.00, if applicable $20.00 dry ice
Shipping to:
United States
Delivery in 12 to 14 Business Days
Quick Overview for Recombinant CD22 (Pinatuzumab Biosimilar) antibody (ABIN7597912)
Target
CD22 (Pinatuzumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Humanized
Clonality
Chimeric
Conjugate
This CD22 (Pinatuzumab Biosimilar) antibody is un-conjugated
Application
Please inquire
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Research Grade Pinatuzumab Biosimilar Antibody
-
Specificity
- Sialic acid-binding Ig-like lectin 2, Siglec-2, CD22, T-cell surface antigen Leu-14, BL-CAM, SIGLEC2, B-lymphocyte cell adhesion molecule, B-cell receptor CD22
-
Purification
- Protein A or G purified from cell culture supernatant.
-
Purity
- >95 % by SDS-PAGE.
-
Isotype
- IgG1 kappa
-
-
anti-CD22 (Pinatuzumab Biosimilar) antibody
Research Grade Reactivity: Human ELISA Host: Humanized Monoclonal unconjugated Recombinant Antibody
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4.
-
Storage
- 4 °C,-20 °C,-80 °C
-
Storage Comment
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
-
Expiry Date
- 12 months
-
-
- CD22 (Pinatuzumab Biosimilar)
-
Alternative Name
- Pinatuzumab Biosimilar
-
Target Type
- Biosimilar
-
Background
- Sialic acid-binding Ig-like lectin 2, Siglec-2, CD22, T-cell surface antigen Leu-14, BL-CAM, SIGLEC2, B-lymphocyte cell adhesion molecule, B-cell receptor CD22
-
UniProt
- P20273
Target
-
You are here:
